Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1992 2
1993 2
1994 4
1995 4
1996 6
1997 1
1998 6
1999 5
2000 4
2001 4
2002 7
2003 10
2004 6
2005 16
2006 10
2007 16
2008 9
2009 11
2010 13
2011 7
2012 7
2013 11
2014 10
2015 3
2016 9
2017 9
2018 9
2019 5
2020 19
2021 14
2022 15
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

236 results

Results by year

Filters applied: . Clear all
Page 1
Prévention des risques liés à un usage inapproprié/consommation inutile des médicaments.
Cracowski JL, Muller S, Anglade I, Bonnefond G, Bouhanick B, Bouquet S, Cabut S, Daynès P, Denis B, Durand D, Jonville-Béra AP, Lahouegue A, Léo M, Micallef J, Molimard M, Penfornis C, Querol-Ferrer V. Cracowski JL, et al. Among authors: molimard m. Therapie. 2022 Jan-Feb;77(1):69-78. doi: 10.1016/j.therap.2021.12.020. Epub 2022 Jan 4. Therapie. 2022. PMID: 35067334 Free PMC article. French.
Quelle place pour l’automatisation intelligente et l’intelligence artificielle pour préserver et renforcer l’expertise en vigilance devant l’augmentation des déclarations ?
Pariente A, Micallef J, Lahouegue A, Molimard M, Auffret M, Chouchana L, Denis B, Faillie JL, Grandvuillemin A, Letinier L, Pierron E, Pons C, Pujade I, Rubino H, Salvo F. Pariente A, et al. Among authors: molimard m. Therapie. 2023 Jan-Feb;78(1):115-129. doi: 10.1016/j.therap.2022.11.003. Epub 2022 Nov 25. Therapie. 2023. PMID: 36577617 French. No abstract available.
Quelles actions pour lutter contre la désinformation sur les produits de santé ?
Micallef J, Maisonneuve H, Muller S, Molimard M, Bégaud B, Cabut S, Daban M, Drici MD, Gatignol C, Grumblat A, Guaspare-Cartron C, Lasserre B, Mebarki A, Pons C, Prabonnaud F, Raynaud C, Saint-Lary O. Micallef J, et al. Among authors: molimard m. Therapie. 2024 Jan-Feb;79(1):75-86. doi: 10.1016/j.therap.2023.10.004. Epub 2023 Oct 29. Therapie. 2024. PMID: 37985308 French. No abstract available.
Benefit-risk balance of COVID drugs. New prospects.
Cracowski JL, Richard V, Molimard M. Cracowski JL, et al. Among authors: molimard m. Therapie. 2022 Sep-Oct;77(5):505-507. doi: 10.1016/j.therap.2022.09.001. Epub 2022 Sep 6. Therapie. 2022. PMID: 36100496 Free PMC article. No abstract available.
Information et communication sur les risques liés au médicament et son bon usage auprès des professionnels de santé et du public : principe de précaution, gestion du risque, communication pendant et en dehors des situations de crise.
Molimard M, Bernaud C, Lechat P; et les participants à la table ronde N°6 de Giens XXIX :; Bejan-Angoulvant T, Benattia C, Benkritly A, Braunstein D, Cabut S, David N, Fourrier-Réglat A, Gallet B, Gersberg M, Goni S, Jolliet P, Lamarque-Garnier V, Le Jeunne C, Leurs I, Liard F, Malbezin M, Micallef J, Nguon M. Molimard M, et al. Therapie. 2014 Jul-Aug;69(4):355-60. doi: 10.2515/therapie/2014044. Therapie. 2014. PMID: 27393228 French. No abstract available.
The French Levothyrox® crisis: We did the best we could but….
Mouly S, Roustit M, Bagheri H, Perault-Pochat MC, Molimard M, Bordet R. Mouly S, et al. Among authors: molimard m. Therapie. 2019 Jun;74(3):431-435. doi: 10.1016/j.therap.2019.01.003. Epub 2019 Jan 19. Therapie. 2019. PMID: 30737052 No abstract available.
236 results